Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruna Scaggiante

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Journal of Pharmaceutical and Biomedical Analysis|August 27, 2019
A rapid and specific method to simultaneously quantify eukaryotic elongation factor 1A1 and A2 protein levels in cancer cellsAlessandra Bosutti, Odeta Kalaja, Fabrizio Zanconati, et al.
International Journal of Molecular Sciences|June 10, 2023
Next-Generation Sequencing and Triple-Negative Breast Cancer: Insights and ApplicationsDomenico Tierno, Gabriele Grassi, Serena Scomersi, et al.
Plos One|June 21, 2019
Elevated levels of eEF1A2 protein expression in triple negative breast cancer relate with poor prognosisFabiola Giudici, Elisabetta Petracci, Oriana Nanni, et al.
International Journal of Molecular Sciences|February 13, 2025
Circulating Cell-Free DNA Integrity for Breast and Prostate Cancer: What Is the Landscape for Clinical Management of the Most Common Cancers in Women and Men?Navid Sobhani, Domenico Tierno, Nicola Pavan, et al.
Stress and Health : Journal of the International Society for the Investigation of Stress|January 23, 2024
The effect of mindfulness-based interventions on biomarkers in cancer patients and survivors: A systematic reviewAlessio Matiz, Bruna Scaggiante, Ciro Conversano, et al.
World Journal of Gastroenterology|February 28, 2014
Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentialsBruna Scaggiante, Maryam Kazemi, Gabriele Pozzato, et al.
Pharmaceutics|April 23, 2022
An Overview of siRNA Delivery Strategies for Urological CancersNadia Halib, Nicola Pavan, Carlo Trombetta, et al.
Current Drug Metabolism|January 13, 2011
Improving siRNA bio-distribution and minimizing side effectsBruna Scaggiante, Barbara Dapas, Rossella Farra, et al.
Cancer Immunology, Immunotherapy : CII|August 29, 2023
Cancer management during the COVID-19 world pandemicNavid Sobhani, Giuseppina Mondani, Giandomenico Roviello, et al.
International Journal of Pharmaceutics|April 21, 2016
Aptamer targeting of the elongation factor 1A impairs hepatocarcinoma cells viability and potentiates bortezomib and idarubicin effectsBruna Scaggiante, Rosella Farra, Barbara Dapas, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Journal of Pharmaceutical and Biomedical Analysis|August 27, 2019
A rapid and specific method to simultaneously quantify eukaryotic elongation factor 1A1 and A2 protein levels in cancer cellsAlessandra Bosutti, Odeta Kalaja, Fabrizio Zanconati, et al.
International Journal of Molecular Sciences|June 10, 2023
Next-Generation Sequencing and Triple-Negative Breast Cancer: Insights and ApplicationsDomenico Tierno, Gabriele Grassi, Serena Scomersi, et al.
Plos One|June 21, 2019
Elevated levels of eEF1A2 protein expression in triple negative breast cancer relate with poor prognosisFabiola Giudici, Elisabetta Petracci, Oriana Nanni, et al.
International Journal of Molecular Sciences|February 13, 2025
Circulating Cell-Free DNA Integrity for Breast and Prostate Cancer: What Is the Landscape for Clinical Management of the Most Common Cancers in Women and Men?Navid Sobhani, Domenico Tierno, Nicola Pavan, et al.
Stress and Health : Journal of the International Society for the Investigation of Stress|January 23, 2024
The effect of mindfulness-based interventions on biomarkers in cancer patients and survivors: A systematic reviewAlessio Matiz, Bruna Scaggiante, Ciro Conversano, et al.
World Journal of Gastroenterology|February 28, 2014
Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentialsBruna Scaggiante, Maryam Kazemi, Gabriele Pozzato, et al.
Pharmaceutics|April 23, 2022
An Overview of siRNA Delivery Strategies for Urological CancersNadia Halib, Nicola Pavan, Carlo Trombetta, et al.
Current Drug Metabolism|January 13, 2011
Improving siRNA bio-distribution and minimizing side effectsBruna Scaggiante, Barbara Dapas, Rossella Farra, et al.
Cancer Immunology, Immunotherapy : CII|August 29, 2023
Cancer management during the COVID-19 world pandemicNavid Sobhani, Giuseppina Mondani, Giandomenico Roviello, et al.
International Journal of Pharmaceutics|April 21, 2016
Aptamer targeting of the elongation factor 1A impairs hepatocarcinoma cells viability and potentiates bortezomib and idarubicin effectsBruna Scaggiante, Rosella Farra, Barbara Dapas, et al.
Pageof 6